EA200600386A1 - Фармацевтические композиции и способы предотвращения рака молочной железы и яичников - Google Patents
Фармацевтические композиции и способы предотвращения рака молочной железы и яичниковInfo
- Publication number
- EA200600386A1 EA200600386A1 EA200600386A EA200600386A EA200600386A1 EA 200600386 A1 EA200600386 A1 EA 200600386A1 EA 200600386 A EA200600386 A EA 200600386A EA 200600386 A EA200600386 A EA 200600386A EA 200600386 A1 EA200600386 A1 EA 200600386A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- prevention
- ovarians
- methods
- pharmaceutical compositions
- breast cancer
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 229910052711 selenium Inorganic materials 0.000 abstract 2
- 239000011669 selenium Substances 0.000 abstract 2
- 206010033128 Ovarian cancer Diseases 0.000 abstract 1
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL361597A PL214402B1 (pl) | 2003-08-11 | 2003-08-11 | Zastosowanie selenu albo jego zwiazku do otrzymywania srodka do obnizania odziedziczonego ryzyka zachorowania na raka piersi lub jajnika |
PCT/PL2004/000063 WO2005013951A2 (en) | 2003-08-11 | 2004-08-10 | Pharmaceutical compositions for preventing breast and ovarian cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200600386A1 true EA200600386A1 (ru) | 2006-12-29 |
Family
ID=34132453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600386A EA200600386A1 (ru) | 2003-08-11 | 2004-08-10 | Фармацевтические композиции и способы предотвращения рака молочной железы и яичников |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1660060A2 (ja) |
JP (1) | JP2007502270A (ja) |
KR (1) | KR20060066719A (ja) |
CN (1) | CN1835740A (ja) |
AU (1) | AU2004263070A1 (ja) |
CA (1) | CA2535506A1 (ja) |
EA (1) | EA200600386A1 (ja) |
PL (1) | PL214402B1 (ja) |
WO (1) | WO2005013951A2 (ja) |
ZA (1) | ZA200602081B (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006032074A1 (en) * | 2004-09-21 | 2006-03-30 | Velacor Therapeutics Pty Ltd | Inorganic selenium for treatment of cancer |
MX2009010439A (es) * | 2007-03-26 | 2009-10-20 | Decode Genetics Ehf | Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. |
CN100548311C (zh) | 2007-06-13 | 2009-10-14 | 中国科学技术大学 | 硒代硫酸钠在制备临床补硒和治疗癌症药物中的应用及快速制备方法 |
WO2009043106A1 (en) * | 2007-10-03 | 2009-04-09 | Velacor Therapeutics Pty Ltd | Inorganic selenium and angiogenesis |
EP2313529A2 (en) * | 2008-03-13 | 2011-04-27 | Pomorska Akademia Medyczna | Method for determining reduced predisposition to cancer based on genetic profile |
KR101026291B1 (ko) * | 2008-06-30 | 2011-03-31 | 주식회사 태강 | SeO2 doped W-Mo-Li 화합물을 함유한 항암제 조성물 |
GB0916010D0 (en) * | 2009-09-11 | 2009-10-28 | Isis Innovation | JMJD2 demethylase inhibitors |
WO2012067525A1 (en) | 2010-11-18 | 2012-05-24 | Pomorski Uniwersytet Medyczny | Genotypes and selenium level as a markers of breast/ovarian cancer risk in brca1 mutation carriers |
CN103608006B (zh) * | 2011-04-01 | 2017-07-07 | 伊亚索梅股份公司 | 包含n‑乙酰基‑l‑半胱氨酸的组合及其用途 |
CN114533753A (zh) * | 2013-03-15 | 2022-05-27 | 全技术公司 | 含硒组合物及其治疗和预防与线粒体功能障碍有关的疾病或病症的应用 |
US10201559B2 (en) * | 2014-03-14 | 2019-02-12 | Alltech, Inc. | Compositions of selenoorganic compounds and methods of use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19825746A1 (de) * | 1998-06-09 | 1999-12-16 | Biosyn Arzneimittel Gmbh | Kombination von Selen-haltigen Verbindungen mit Zytostatika |
-
2003
- 2003-08-11 PL PL361597A patent/PL214402B1/pl unknown
-
2004
- 2004-08-10 EP EP04775169A patent/EP1660060A2/en not_active Withdrawn
- 2004-08-10 CN CNA2004800231246A patent/CN1835740A/zh active Pending
- 2004-08-10 EA EA200600386A patent/EA200600386A1/ru unknown
- 2004-08-10 CA CA002535506A patent/CA2535506A1/en not_active Abandoned
- 2004-08-10 AU AU2004263070A patent/AU2004263070A1/en not_active Abandoned
- 2004-08-10 WO PCT/PL2004/000063 patent/WO2005013951A2/en active Application Filing
- 2004-08-10 JP JP2006523155A patent/JP2007502270A/ja not_active Withdrawn
- 2004-08-10 KR KR1020067002810A patent/KR20060066719A/ko not_active Application Discontinuation
-
2006
- 2006-03-10 ZA ZA200602081A patent/ZA200602081B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL361597A1 (en) | 2005-02-21 |
CN1835740A (zh) | 2006-09-20 |
ZA200602081B (en) | 2007-05-30 |
JP2007502270A (ja) | 2007-02-08 |
AU2004263070A1 (en) | 2005-02-17 |
WO2005013951A3 (en) | 2005-09-15 |
PL214402B1 (pl) | 2013-07-31 |
WO2005013951A2 (en) | 2005-02-17 |
CA2535506A1 (en) | 2005-02-17 |
EP1660060A2 (en) | 2006-05-31 |
KR20060066719A (ko) | 2006-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200601273A1 (ru) | Новая кристаллическая форма v агомелатина, способ её получения и фармацевтические композиции, которые её содержат | |
EA200601274A1 (ru) | Новая кристаллическая форма iii агомелатина, способ её получения и фармацевтические композиции, которые её содержат | |
BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
EA200601271A1 (ru) | Новая кристаллическая форма iv агомелатина, способ её получения и фармацевтические композиции, которые её содержат | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
DK1853602T3 (da) | Kemiske forbindelser | |
DK1853588T3 (da) | Kemiske forbindelser | |
EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
EA200700225A1 (ru) | Аналоги тетрапептида | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
EA200701930A1 (ru) | Производные пиримидина для лечения гиперпролиферативных нарушений | |
CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
EA200300103A1 (ru) | НОВАЯ β КРИСТАЛЛИЧЕСКАЯ ФОРМА ТРЕТ-БУТИЛАМИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЕЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
PL376324A1 (en) | Piperazinyl and diazapanyl benzamides and benzthioamides | |
TW200616977A (en) | Enantiomers of selected fused heterocyclics and uses thereof | |
EA200600386A1 (ru) | Фармацевтические композиции и способы предотвращения рака молочной железы и яичников | |
EA200801777A1 (ru) | α КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ | |
MX2007001954A (es) | Heterociclicos fusionados seleccionados y sus usos. | |
EA200600018A1 (ru) | Производные никотинамида, полезные в качестве ингибиторов фдэ4 | |
EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
EA200500045A1 (ru) | Новые соединения, их применение и получение | |
ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
EA200701881A1 (ru) | 1,3-тиазол-5-карбоксамиды, используемые в качестве противораковых химиотерапевтических агентов |